Bo Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bo Chang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Di Wang
The First School of Clinical Medicine, Southern Medical University; Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China
1 shared publication - Fan Deng
Department of Immunology School of Basic Medical Sciences Southern Medical University Guangzhou Guangdong China fimmu.com
1 shared publication - Jia Zhou
Department of Immunology, Guangdong Province Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
1 shared publication - Jialiang Luo
Institute of Medical Research, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
1 shared publication - Junxiang Zeng
Department of Bioinformation School of Basic Medical Sciences Southern Medical University Guangzhou Guangdong China fimmu.com
1 shared publication - Ledong Sun
Department of Dermatology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 15 April 2023
- Published by Wiley in Mediators of Inflammation
- Vol. 2023, 1-8
The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target
Atopic dermatitis (AD) is a kind of chronic skin disease with inflammatory infiltration, characterized by skin barrier dysfunction, immune response dysregulation, and skin dysbiosis. Thymic stromal lymphopoietin (TSLP) acts as a regulator of immune response, positively associated with AD deterioration. Mainly secreted by keratinocytes, TSLP interacts with multiple immune cells (including dendritic cells, T cells, and mast cells), following induction of Th2-oriented immune response during the pathogenesis of AD. This article primarily focuses on the TSLP biological function, the relationship between TSLP and different cell populations, and the AD treatments targeting TSLP.
- 15 April 2023
- Published by Wiley in Mediators of Inflammation
- Vol. 2023, 1-8
Open AccessThe Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target
Atopic dermatitis (AD) is a kind of chronic skin disease with inflammatory infiltration, characterized by skin barrier dysfunction, immune response dysregulation, and skin dysbiosis. Thymic stromal lymphopoietin (TSLP) acts as a regulator of immune response, positively associated with AD deterioration. Mainly secreted by keratinocytes, TSLP interacts with multiple immune cells (including dendritic cells, T cells, and mast cells), following induction of Th2-oriented immune response during the pathogenesis of AD. This article primarily focuses on the TSLP biological function, the relationship between TSLP and different cell populations, and the AD treatments targeting TSLP.